Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Other financing activities: 2015-2021

Historic Other financing activities for ImmunityBio (IBRX) over the last 5 years, with Dec 2021 value amounting to $1.4 million.

  • ImmunityBio's Other financing activities fell 629.45% to -$1.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.3 million, marking a year-over-year increase of 2087.88%. This contributed to the annual value of $1.4 million for FY2021, which is N/A change from last year.
  • ImmunityBio's Other financing activities amounted to $1.4 million in FY2021, which was up 1,066.67% from $123,000 recorded in FY2018.
  • ImmunityBio's 5-year Other financing activities high stood at $1.4 million for FY2021, and its period low was $123,000 during FY2018.
  • Moreover, its 1-year median value for Other financing activities was $1.4 million (2021), whereas its average is $1.4 million.
  • Data for ImmunityBio's Other financing activities shows a maximum YoY crashed of 88.16% (in 2018) over the last 5 years.
  • Over the past 3 years, ImmunityBio's Other financing activities (Yearly) stood at $1.0 million in 2017, then crashed by 88.16% to $123,000 in 2018, then reached $1.4 million in 2021.